“fda” Archives

in
Entry Author Date Location
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data 07/26/17 Boston
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
With Helix’s Help, Lose It Adds Genetic Insights to Weight Loss App 07/24/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
NeuroVia Raises $14M to Test Drug for Rare, Fatal Metabolic Disease 07/20/17 Boston
StrataGraft Skin Treatment Gets New FDA Regenerative Med Status 07/19/17 Wisconsin
Radius Health Ramps Up for Market as FDA Rejects Rival Amgen Drug 07/17/17 Boston
Five Questions for … Austin Biotech Entrepreneur Laura Bosworth 07/14/17 Texas
Akcea Slashes IPO Price Ahead of Filing for Rare Disease Drug 07/14/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Unanimous Advice To FDA: Approve Landmark CAR-T Cancer Therapy 07/12/17 National
Exact, Microscopy, FairSquare, & More: This Week’s WI Watchlist 07/12/17 Wisconsin
Allurion Technologies Adds $27M for Nonsurgical Weight Loss Balloon 07/11/17 Boston
Sanofi Shores Up Flu Vaccine Business With Protein Sciences Deal 07/11/17 New York
Eyeing Recent FDA Decision, Promega to Seek Approvals for MSI Assay 07/10/17 Wisconsin
Before Key Meeting, FDA Stresses Risks of Novartis CAR-T Cancer Therapy 07/10/17 National
Roundup: LiveOak, Memorial Hermann, AT&T, March Capital, & DigniCap 07/10/17 Texas
Inotek Considers “Strategic Options” After Glaucoma Trial Failure 07/07/17 Boston
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
With Triage System, Companies See Toehold for A.I. in Radiology 07/06/17 Seattle
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal 07/06/17 New York
New U-M Grant Funding Will Advance Clinical Research, Train Teachers 07/06/17 Detroit Ann Arbor
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug 06/29/17 Boston
Atlas Venture Unveils New $350M Fund for Seed Biotech Investments 06/29/17 Boston
LogicBio Lands $45M for Gene Therapies in Rare Pediatric Diseases 06/28/17 Boston
Alder Drug Cuts Down Migraines in Study, But Still Trails Rivals 06/27/17 Seattle
Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say. 06/26/17 Boston
Page 1 of 62 next page »